Niagen Bioscience (NAGE) appoints Dr. Pinchas Cohen to SAB
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St on track for subdued September start as high yields, oil prices dent sentiment
- Oil up more than 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory Board
April 29, 2025 8:32 AM EDTAppointment of renowned gerontologist and mitochondrial biology expert underscores Niagen Biosciences commitment to advancing cutting-edge NAD+ and healthspan research
LOS ANGELES--(BUSINESS WIRE)-- Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the... More
